Literature DB >> 32440991

Obstructive sleep apnea syndrome and risk of renal impairment: a systematic review and meta-analysis with trial sequential analysis.

Tongtong Liu1, Yongli Zhan1, Yuyang Wang1, Qian Li1, Huimin Mao2.   

Abstract

BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is associated with a variety of systemic diseases. Among patients with chronic kidney diseases (CKD), the prevalence of OSAS is high. OSAS can induce progression of CKD. However, whether or not OSAS can cause renal damage in healthy people is not clear. Thus, the purpose of this meta-analysis was to elucidate whether or not there was an association between OSAS and early renal damage.
METHODS: PubMed, Embase Database, Cochrane Library, Web of Science, China National Knowledge Infrastructure, China Biology Medicine Database, Chinese Scientific Journals Database, and Wanfang Database were searched systematically. The relative risk (RR), weighted mean difference (WMD), and 95% confidence intervals (CI) were used to evaluate the relationship between OSAS and early renal damage. Funnel plot and Egger's test were used to evaluate publication bias, and trial sequential analysis (TSA) was employed to verify the sufficiency of the research conclusions.
RESULTS: A total of 18 studies were analyzed comprising 4,567 participants. Compared with the healthy control group, levels of cystatin C (MD = 0.530, 95% CI 0.423, 0.637, P < 0.01) and proteinuria in patients with OSAS were significantly increased, while the levels of estimated glomerular filtration rate (eGFR) (MD = - 0.194, 95% CI - 0.268, - 0.121, P < 0.01) were significantly decreased. Furthermore, patients with OSAS also had an increased risk of CKD. Subgroup analysis showed that compared with patients without OSAS, the level of serum cystatin C in patients with OSAS was significantly increased independent of hypertension and diabetes, and the eGFR was significantly decreased in patients with moderate to severe OSAS and comorbid hypertension and/or diabetes.
CONCLUSION: In this meta-analysis, OSAS was associated with a higher risk of early renal damage. Patients with OSAS and comorbid hypertension and/or diabetes appear to suffer from severe renal damage.

Entities:  

Keywords:  Cystatin C; Meta-analysis; Obstructive sleep apnea syndrome; Renal damage; Trial sequential analysis

Year:  2020        PMID: 32440991      PMCID: PMC7987709          DOI: 10.1007/s11325-020-02090-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  44 in total

1.  Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep.

Authors:  Euphemia G Daskalopoulou; Christos Liavvas; Christos T Nakas; Emmanuel G Vlachogiannis; Demosthenes Bouros; Nicholas V Dombros
Journal:  Sleep Breath       Date:  2010-09-25       Impact factor: 2.816

2.  Relationship between serum adiponectin and bone mineral density in male patients with obstructive sleep apnea syndrome.

Authors:  Dong-Dong Chen; Jie-Feng Huang; Qi-Chang Lin; Gong-Ping Chen; Jian-Ming Zhao
Journal:  Sleep Breath       Date:  2017-03-25       Impact factor: 2.816

3.  Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome.

Authors:  Athanasios Voulgaris; Kostas Archontogeorgis; Evangelia Nena; Christina Tsigalou; Maria Xanthoudaki; Maria Kouratzi; Grigorios Tripsianis; Marios Froudarakis; Paschalis Steiropoulos
Journal:  Sleep Breath       Date:  2018-06-26       Impact factor: 2.816

4.  Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  Chest       Date:  2012-01-05       Impact factor: 9.410

5.  Renal functions in obstructive sleep apnea patients.

Authors:  Meral Uyar; Vedat Davutoğlu; Nevhiz Gündoğdu; Deniz Kosovalı; İbrahim Sarı
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

6.  Night and day proteinuria in patients with sleep apnea.

Authors:  Patricia Mello; Margaret Franger; Ziad Boujaoude; Mark Adaimy; Elena Gelfand; Jonathan Kass; Lawrence S Weisberg
Journal:  Am J Kidney Dis       Date:  2004-10       Impact factor: 8.860

Review 7.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

8.  Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.

Authors:  Shin-ichi Kinebuchi; Junichiro J Kazama; Makoto Satoh; Kunihiko Sakai; Hideaki Nakayama; Hirohisa Yoshizawa; Ichiei Narita; Eiichi Suzuki; Fumitake Gejyo
Journal:  Clin Sci (Lond)       Date:  2004-09       Impact factor: 6.124

9.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 10.  Biochemical Markers of Renal Function.

Authors:  Danijela Krstic; Nenad Tomic; Branimir Radosavljevic; Natasa Avramovic; Vesna Dragutinovic; Sanja Radojevic Skodric; Mirjana Colovic
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more
  3 in total

Review 1.  Prevalence of sleep disorders in children with chronic kidney disease: a meta-analysis.

Authors:  Kun-Tai Kang; Ming-Tzer Lin; Yin-Cheng Chen; Chia-Hsuan Lee; Wei-Chung Hsu; Ray-E Chang
Journal:  Pediatr Nephrol       Date:  2022-04-20       Impact factor: 3.651

2.  Development and assessment of a risk prediction model for moderate-to-severe obstructive sleep apnea.

Authors:  Xiangru Yan; Liying Wang; Chunguang Liang; Huiying Zhang; Ying Zhao; Hui Zhang; Haitao Yu; Jinna Di
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

3.  An umbrella review of systematic reviews and meta-analyses of observational investigations of obstructive sleep apnea and health outcomes.

Authors:  Weiwei Chen; Yuting Li; Liliangzi Guo; Chenxing Zhang; Shaohui Tang
Journal:  Sleep Breath       Date:  2021-04-24       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.